Rexahn Pharmaceuticals (RNN)
Rexahn Pharmaceuticals News
Rexahn Pharmaceuticals Announces Publication of New Preclinical Research Data for Novel Anti-Cancer Compound RX-3117
Business Wire about a day agoRexahn Pharmaceuticals, Inc. , a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today a
REXAHN PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
about 22 days agoRexahn Pharmaceuticals Submits Archexin Phase II Protocol for Ovarian Cancer to FDA
Benzinga about 23 days agoRexahn Pharmaceuticals Issued Japanese Patent for New Anti-cancer Compounds
Business Wire about 31 days agoRexahn Pharmaceuticals, Inc. , a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that the Japanese Patent Office has issued to the Company patent No.
Rexahn Pharmaceuticals Focus On Cancer May Pay Off
about 62 days agoRexahn Pharmaceuticals to Present Data on Novel Anti-Cancer Small Molecule RX-3117 at AACR 103rd Annual Meeting
Business Wire about 65 days agoRexahn Pharmaceuticals, Inc. , a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that i
REXAHN PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report
about 76 days agoEarnings Scheduled For March 16
Benzinga about 76 days agoRexahn Pharmaceuticals Enrolls First Subject in Exploratory Phase I Clinical Study of RX-3117
Benzinga about 79 days agoRexahn Pharmaceuticals Publishes New Preclinical Data for Quinoxalinyl-Piperazine Compounds
Benzinga about 127 days agoBenzinga's Microcap Movers for Wednesday January 18, 2012
Benzinga about 134 days agoRodman & Renshaw Changes Rating on Rexahn Pharmaceuticals to Market Perform
Benzinga about 134 days agoRodman & Renshaw Cuts Rexahn Pharma (RNN) to Market Perform
Street Insider about 134 days agoYou may also be interested in these RNN related companies
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| RNN | 0.408 | +0.00 | +0.00% | 38.90M |
| RNIN | 0.76 | +0.01 | +1.33% | 17.46M |
| RNF | 23.78 | +0.38 | +1.62% | |
| RNET | 15.33 | +0.13 | +0.86% | 234.69M |
| RNE | 13.72 | -0.25 | -1.79% | |
| RMTR | 1.86 | -0.10 | -5.10% | 69.24M |
| RMT | 8.70 | -0.02 | -0.23% | |
| RMKR | 0.65 | +0.02 | +3.14% | 17.43M |
| RMD | 30.70 | -0.42 | -1.35% | 4.487B |
| RMCF | 10.45 | -0.01 | -0.10% | 64.05M |
